SKU: T63264-25mg-TM

EGFR-IN-33

Blue Ice

Specifications

Specification	Details
Additional Information	EGFR-IN-33, an acrylamide derivative, is a low-toxicity antitumor agent and a potent inhibitor of EGFR. Among others, overexpression and mutation of the epidermal growth factor receptor (EGFR) has been shown to lead to uncontrolled cell growth and is associated with the progression of most cancer diseases, especially NSCLC. EGFR-IN-33 exhibits potential for the study of EGFR mutation-related diseases (information from patent WO2021185348A1, compound 13).

Specification

Details

Additional Information

EGFR-IN-33, an acrylamide derivative, is a low-toxicity antitumor agent and a potent inhibitor of EGFR. Among others, overexpression and mutation of the epidermal growth factor receptor (EGFR) has been shown to lead to uncontrolled cell growth and is associated with the progression of most cancer diseases, especially NSCLC. EGFR-IN-33 exhibits potential for the study of EGFR mutation-related diseases (information from patent WO2021185348A1, compound 13).

Resources

PDF

Datasheet

Catalog Number

T63264-25mg-TM

Name

EGFR-IN-33

Price(25 mg)

← Back to products